Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

Evaluating the Safety and Immune Response to Two Doses of a Dengue Virus Vaccine Administered 12 Months Apart
A Phase 1 Evaluation of the Safety and Immunogenicity of a Booster Dose of TV003 Administered 12 Months After Initial Vaccination With TV003
Status: Enrolling
Updated:  12/14/2015
Center for Immunization Research - Johns Hopkins Bloomberg School of Public Health
2303
mi
from 91732
Baltimore, MD
Evaluating the Safety and Immune Response to Two Doses of a Dengue Virus Vaccine Administered 12 Months Apart
A Phase 1 Evaluation of the Safety and Immunogenicity of a Booster Dose of TV003 Administered 12 Months After Initial Vaccination With TV003
Status: Enrolling
Updated: 12/14/2015
Center for Immunization Research - Johns Hopkins Bloomberg School of Public Health
2303
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
Evaluating the Safety and Immune Response to Two Doses of a Dengue Virus Vaccine Administered 12 Months Apart
A Phase 1 Evaluation of the Safety and Immunogenicity of a Booster Dose of TV003 Administered 12 Months After Initial Vaccination With TV003
Status: Enrolling
Updated:  12/14/2015
University of Vermont Vaccine Testing Center
2467
mi
from 91732
Burlington, VT
Evaluating the Safety and Immune Response to Two Doses of a Dengue Virus Vaccine Administered 12 Months Apart
A Phase 1 Evaluation of the Safety and Immunogenicity of a Booster Dose of TV003 Administered 12 Months After Initial Vaccination With TV003
Status: Enrolling
Updated: 12/14/2015
University of Vermont Vaccine Testing Center
2467
mi
from 91732
Burlington, VT
Click here to add this to my saved trials
Evaluating the Safety and Immune Response to a Dengue Virus Vaccine in Healthy Adults
A Phase 1 Evaluation of the Safety and Immunogenicity of rDEN2Δ30-7169, a Live Attenuated Monovalent Dengue Virus Vaccine
Status: Enrolling
Updated:  12/14/2015
John Hopkins Bloomberg School of Public Health - Center for Immunization Research (CIR)
2304
mi
from 91732
Baltimore, MD
Evaluating the Safety and Immune Response to a Dengue Virus Vaccine in Healthy Adults
A Phase 1 Evaluation of the Safety and Immunogenicity of rDEN2Δ30-7169, a Live Attenuated Monovalent Dengue Virus Vaccine
Status: Enrolling
Updated: 12/14/2015
John Hopkins Bloomberg School of Public Health - Center for Immunization Research (CIR)
2304
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
Evaluating the Safety and Effectiveness of a Dengue Virus Vaccine in Healthy Adults
A Phase 1 Evaluation of the Protective Efficacy of a Single Dose of the Live Attenuated Tetravalent Dengue Vaccine TV003 to Protect Against Infection With Attenuated DENV-2, rDEN2∆30-7169
Status: Enrolling
Updated:  12/14/2015
Center for Immunization Research (CIR), Johns Hopkins Bloomberg School of Public Health
2303
mi
from 91732
Baltimore, MD
Evaluating the Safety and Effectiveness of a Dengue Virus Vaccine in Healthy Adults
A Phase 1 Evaluation of the Protective Efficacy of a Single Dose of the Live Attenuated Tetravalent Dengue Vaccine TV003 to Protect Against Infection With Attenuated DENV-2, rDEN2∆30-7169
Status: Enrolling
Updated: 12/14/2015
Center for Immunization Research (CIR), Johns Hopkins Bloomberg School of Public Health
2303
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
Evaluating the Safety and Effectiveness of a Dengue Virus Vaccine in Healthy Adults
A Phase 1 Evaluation of the Protective Efficacy of a Single Dose of the Live Attenuated Tetravalent Dengue Vaccine TV003 to Protect Against Infection With Attenuated DENV-2, rDEN2∆30-7169
Status: Enrolling
Updated:  12/14/2015
University of Vermont Vaccine Testing Center
2467
mi
from 91732
Burlington, VT
Evaluating the Safety and Effectiveness of a Dengue Virus Vaccine in Healthy Adults
A Phase 1 Evaluation of the Protective Efficacy of a Single Dose of the Live Attenuated Tetravalent Dengue Vaccine TV003 to Protect Against Infection With Attenuated DENV-2, rDEN2∆30-7169
Status: Enrolling
Updated: 12/14/2015
University of Vermont Vaccine Testing Center
2467
mi
from 91732
Burlington, VT
Click here to add this to my saved trials
Respiratory Viral Infections in Pediatric Transplantation
A Multicenter Consortium to Define the Epidemiology and Outcomes of Respiratory Viral Infections in Pediatric Transplant Recipients
Status: Enrolling
Updated:  12/14/2015
Duke University
2203
mi
from 91732
Durham, NC
Respiratory Viral Infections in Pediatric Transplantation
A Multicenter Consortium to Define the Epidemiology and Outcomes of Respiratory Viral Infections in Pediatric Transplant Recipients
Status: Enrolling
Updated: 12/14/2015
Duke University
2203
mi
from 91732
Durham, NC
Click here to add this to my saved trials
Rapid Detection of Group B Streptococcus (Strep)-Labor and Delivery Study
Rapid Detection of Group B Streptococcus Using a Bedside Microfluidics Device: Labor and Delivery Study
Status: Enrolling
Updated:  12/14/2015
University of Michigan Hospital
1934
mi
from 91732
Ann Arbor, MI
Rapid Detection of Group B Streptococcus (Strep)-Labor and Delivery Study
Rapid Detection of Group B Streptococcus Using a Bedside Microfluidics Device: Labor and Delivery Study
Status: Enrolling
Updated: 12/14/2015
University of Michigan Hospital
1934
mi
from 91732
Ann Arbor, MI
Click here to add this to my saved trials
Study of PRO 140 by Subcutaneous Administration in Adult Subjects With HIV -1 Infection
A Phase 2a, Randomized, Double-blind, Placebo Controlled Study of PRO 140 by Subcutaneous Administration in Adult Subjects With Human Immunodeficiency Virus Type 1 Infection
Status: Enrolling
Updated:  12/14/2015
Progenics Pharmaceuticals, Inc.
2439
mi
from 91732
Tarrytown, NY
Study of PRO 140 by Subcutaneous Administration in Adult Subjects With HIV -1 Infection
A Phase 2a, Randomized, Double-blind, Placebo Controlled Study of PRO 140 by Subcutaneous Administration in Adult Subjects With Human Immunodeficiency Virus Type 1 Infection
Status: Enrolling
Updated: 12/14/2015
Progenics Pharmaceuticals, Inc.
2439
mi
from 91732
Tarrytown, NY
Click here to add this to my saved trials
Evaluating Three Grams Daily Valacyclovir in Patients With Chronic Hepatitis C and HSV-2 Infection (Phase I)
Evaluating Three Grams Daily Valacyclovir in Patients With Chronic Hepatitis C and Herpes Simplex Virus 2 (HSV-2) Infection (Phase I)
Status: Enrolling
Updated:  12/15/2015
G.V. (Sonny) Montgomery VA Medical Center, Jackson, MS
1609
mi
from 91732
Jackson, MS
Evaluating Three Grams Daily Valacyclovir in Patients With Chronic Hepatitis C and HSV-2 Infection (Phase I)
Evaluating Three Grams Daily Valacyclovir in Patients With Chronic Hepatitis C and Herpes Simplex Virus 2 (HSV-2) Infection (Phase I)
Status: Enrolling
Updated: 12/15/2015
G.V. (Sonny) Montgomery VA Medical Center, Jackson, MS
1609
mi
from 91732
Jackson, MS
Click here to add this to my saved trials
Mechanisms of Resistance and Molecular Epidemiology of Commonly Encountered Multi-Resistant Bacteria
Mechanisms of Resistance and Molecular Epidemiology of Commonly Encountered Multi-Resistant Bacteria
Status: Enrolling
Updated:  12/16/2015
University of Pittsburgh Medical Center
2121
mi
from 91732
Pittsburgh, PA
Mechanisms of Resistance and Molecular Epidemiology of Commonly Encountered Multi-Resistant Bacteria
Mechanisms of Resistance and Molecular Epidemiology of Commonly Encountered Multi-Resistant Bacteria
Status: Enrolling
Updated: 12/16/2015
University of Pittsburgh Medical Center
2121
mi
from 91732
Pittsburgh, PA
Click here to add this to my saved trials
Community - Associated Extended-spectrum Beta-lactamases (ESBL)
Community - Associated Extended-spectrum Beta-lactamases (ESBL)
Status: Enrolling
Updated:  12/16/2015
University of Pittsburgh Medical Center
2121
mi
from 91732
Pittsburgh, PA
Community - Associated Extended-spectrum Beta-lactamases (ESBL)
Community - Associated Extended-spectrum Beta-lactamases (ESBL)
Status: Enrolling
Updated: 12/16/2015
University of Pittsburgh Medical Center
2121
mi
from 91732
Pittsburgh, PA
Click here to add this to my saved trials
Optimizing Dosing of Colistin for Infections Resistant to All Other Antibiotics, Approved NIH Protocol Dated 12.06.07(DMID Protocol #07-0036)
Pharmacokinetics and Pharmacodynamics of Intravenous Colistin- Pilot Study
Status: Enrolling
Updated:  12/16/2015
University of Pittsburgh Medical Center
2121
mi
from 91732
Pittsburgh, PA
Optimizing Dosing of Colistin for Infections Resistant to All Other Antibiotics, Approved NIH Protocol Dated 12.06.07(DMID Protocol #07-0036)
Pharmacokinetics and Pharmacodynamics of Intravenous Colistin- Pilot Study
Status: Enrolling
Updated: 12/16/2015
University of Pittsburgh Medical Center
2121
mi
from 91732
Pittsburgh, PA
Click here to add this to my saved trials
Comparison of the Quantiferon®-TB GOLD (in Tube) Assay With Tuberculin Skin Testing for Detecting Latent Tuberculosis Infection in Patients With Chronic Liver Disease Being Evaluated for or Awaiting Liver Transplantation
Comparison of the Quantiferon®-TB GOLD (in Tube) Assay With Tuberculin Skin Testing for Detecting Latent Tuberculosis Infection in Patients With Chronic Liver Disease Being Evaluated for or Awaiting Liver Transplantation
Status: Enrolling
Updated:  12/16/2015
University of Pittsburgh Medical Center
2121
mi
from 91732
Pittsburgh, PA
Comparison of the Quantiferon®-TB GOLD (in Tube) Assay With Tuberculin Skin Testing for Detecting Latent Tuberculosis Infection in Patients With Chronic Liver Disease Being Evaluated for or Awaiting Liver Transplantation
Comparison of the Quantiferon®-TB GOLD (in Tube) Assay With Tuberculin Skin Testing for Detecting Latent Tuberculosis Infection in Patients With Chronic Liver Disease Being Evaluated for or Awaiting Liver Transplantation
Status: Enrolling
Updated: 12/16/2015
University of Pittsburgh Medical Center
2121
mi
from 91732
Pittsburgh, PA
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
University of Arkansas - Arkansas Childrens Hospital
mi
from 91732
Little Rock, AR
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
University of Arkansas - Arkansas Childrens Hospital
mi
from 91732
Little Rock, AR
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
Wilmington Hospital Health Center
2356
mi
from 91732
Wilmington, DE
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
Wilmington Hospital Health Center
2356
mi
from 91732
Wilmington, DE
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
University of Florida
2104
mi
from 91732
Gainesville, FL
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
University of Florida
2104
mi
from 91732
Gainesville, FL
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
Children's Memorial Hospital-Northwestern University
1729
mi
from 91732
Chicago, IL
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
Children's Memorial Hospital-Northwestern University
1729
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
University of Iowa Hospital
1528
mi
from 91732
Iowa City, IA
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
University of Iowa Hospital
1528
mi
from 91732
Iowa City, IA
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
Boston Children's
2578
mi
from 91732
Boston, MA
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
Boston Children's
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
University of Michigan
1932
mi
from 91732
Ann Arbor, MI
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
University of Michigan
1932
mi
from 91732
Ann Arbor, MI
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
St. Louis University School of Medicine
1566
mi
from 91732
St. Louis, MO
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
St. Louis University School of Medicine
1566
mi
from 91732
St. Louis, MO
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
Oak Orchard Community Health Center
2229
mi
from 91732
Brockport, NY
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
Oak Orchard Community Health Center
2229
mi
from 91732
Brockport, NY
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
Honeoye Falls Family Medicine
2246
mi
from 91732
Honeoye Falls, NY
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
Honeoye Falls Family Medicine
2246
mi
from 91732
Honeoye Falls, NY
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
Mendon Pediatrics
2250
mi
from 91732
Mendon, NY
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
Mendon Pediatrics
2250
mi
from 91732
Mendon, NY
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
Long Pond Pediatrics
2245
mi
from 91732
Rochester, NY
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
Long Pond Pediatrics
2245
mi
from 91732
Rochester, NY
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
Goodman Pediatrics
2248
mi
from 91732
Rochester, NY
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
Goodman Pediatrics
2248
mi
from 91732
Rochester, NY
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
Parkway Pediatrics
2243
mi
from 91732
Rochester, NY
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
Parkway Pediatrics
2243
mi
from 91732
Rochester, NY
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
English Road Pediatrics
2244
mi
from 91732
Rochester, NY
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
English Road Pediatrics
2244
mi
from 91732
Rochester, NY
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
12 Corner Pediatrics
2248
mi
from 91732
Rochester, NY
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
12 Corner Pediatrics
2248
mi
from 91732
Rochester, NY
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
Westside Pediatrics
2239
mi
from 91732
Rochester, NY
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
Westside Pediatrics
2239
mi
from 91732
Rochester, NY
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
Ridgewood Med-Peds
2240
mi
from 91732
Rochester, NY
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
Ridgewood Med-Peds
2240
mi
from 91732
Rochester, NY
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
Nationwide Children's Hospital
1961
mi
from 91732
Columbus, OH
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
Nationwide Children's Hospital
1961
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
Baylor College of Medicine/Texas Children's Hospital
1357
mi
from 91732
Houston, TX
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
Baylor College of Medicine/Texas Children's Hospital
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
The University of Texas, Houston
1357
mi
from 91732
Houston, TX
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
The University of Texas, Houston
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
University of Washington Medical Center
964
mi
from 91732
Seattle, WA
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
University of Washington Medical Center
964
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®
A Phase II, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of IMVAMUNE® Using Three Immunization Schedules and Two Modes of Delivery
Status: Enrolling
Updated:  12/17/2015
Baylor College of Medicine - Molecular Virology and Microbiology
1357
mi
from 91732
Houston, TX
Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®
A Phase II, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of IMVAMUNE® Using Three Immunization Schedules and Two Modes of Delivery
Status: Enrolling
Updated: 12/17/2015
Baylor College of Medicine - Molecular Virology and Microbiology
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®
A Phase II, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of IMVAMUNE® Using Three Immunization Schedules and Two Modes of Delivery
Status: Enrolling
Updated:  12/17/2015
Emory Vaccine Center - The Hope Clinic
1924
mi
from 91732
Decatur, GA
Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®
A Phase II, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of IMVAMUNE® Using Three Immunization Schedules and Two Modes of Delivery
Status: Enrolling
Updated: 12/17/2015
Emory Vaccine Center - The Hope Clinic
1924
mi
from 91732
Decatur, GA
Click here to add this to my saved trials
Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®
A Phase II, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of IMVAMUNE® Using Three Immunization Schedules and Two Modes of Delivery
Status: Enrolling
Updated:  12/17/2015
Saint Louis University - Center for Vaccine Development
1571
mi
from 91732
Saint Louis, MO
Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®
A Phase II, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of IMVAMUNE® Using Three Immunization Schedules and Two Modes of Delivery
Status: Enrolling
Updated: 12/17/2015
Saint Louis University - Center for Vaccine Development
1571
mi
from 91732
Saint Louis, MO
Click here to add this to my saved trials
Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®
A Phase II, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of IMVAMUNE® Using Three Immunization Schedules and Two Modes of Delivery
Status: Enrolling
Updated:  12/17/2015
University of Iowa - Vaccine Research & Education Unit
1528
mi
from 91732
Iowa City, IA
Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®
A Phase II, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of IMVAMUNE® Using Three Immunization Schedules and Two Modes of Delivery
Status: Enrolling
Updated: 12/17/2015
University of Iowa - Vaccine Research & Education Unit
1528
mi
from 91732
Iowa City, IA
Click here to add this to my saved trials
Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®
A Phase II, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of IMVAMUNE® Using Three Immunization Schedules and Two Modes of Delivery
Status: Enrolling
Updated:  12/17/2015
University of Maryland Medical System - General Clinical Research Center (GCRC)
2301
mi
from 91732
Baltimore, MD
Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®
A Phase II, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of IMVAMUNE® Using Three Immunization Schedules and Two Modes of Delivery
Status: Enrolling
Updated: 12/17/2015
University of Maryland Medical System - General Clinical Research Center (GCRC)
2301
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®
A Phase II, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of IMVAMUNE® Using Three Immunization Schedules and Two Modes of Delivery
Status: Enrolling
Updated:  12/17/2015
Group Health Research Institute - Seattle - Vaccines and Infectious Diseases
961
mi
from 91732
Seattle, WA
Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®
A Phase II, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of IMVAMUNE® Using Three Immunization Schedules and Two Modes of Delivery
Status: Enrolling
Updated: 12/17/2015
Group Health Research Institute - Seattle - Vaccines and Infectious Diseases
961
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
Catheter Biofilm Microbiome in Infected Neonatal Catheters.
BIOFILM MICROBIOME AND MICROBIAL DNA LOAD IN NEONATAL CATHETER-ASSOCIATED BLOODSTREAM INFECTIONS
Status: Enrolling
Updated:  12/17/2015
Texas Children's Hospital
1357
mi
from 91732
Houston, TX
Catheter Biofilm Microbiome in Infected Neonatal Catheters.
BIOFILM MICROBIOME AND MICROBIAL DNA LOAD IN NEONATAL CATHETER-ASSOCIATED BLOODSTREAM INFECTIONS
Status: Enrolling
Updated: 12/17/2015
Texas Children's Hospital
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
A Placebo-Controlled, Dose-Escalating Study to Examine the Safety and Tolerability of Single Intravenous Doses of CF-301 in Healthy Subjects
A Phase 1, Placebo-Controlled, Dose-Escalating Study to Examine the Safety and Tolerability of Single Intravenous Doses of CF-301 in Healthy Male and Female Subjects
Status: Enrolling
Updated:  12/17/2015
Clinical Research Facility
1332
mi
from 91732
Lenexa, KA
A Placebo-Controlled, Dose-Escalating Study to Examine the Safety and Tolerability of Single Intravenous Doses of CF-301 in Healthy Subjects
A Phase 1, Placebo-Controlled, Dose-Escalating Study to Examine the Safety and Tolerability of Single Intravenous Doses of CF-301 in Healthy Male and Female Subjects
Status: Enrolling
Updated: 12/17/2015
Clinical Research Facility
1332
mi
from 91732
Lenexa, KA
Click here to add this to my saved trials
Trial of Septra for Uncomplicated Skin Abscesses in Patients at Risk for Community Acquired Methicillin-Resistant Staphylococcus Aureus Infection
Prospective Randomized Double Blind, Placebo-Controlled Trial of Septra for Uncomplicated Skin Abscesses in Patients at Risk for Community Acquired Methicillin-Resistant Staphylococcus Aureus Infection on 30 Day Recurrence Rates.
Status: Enrolling
Updated:  12/17/2015
Wilford Hall Medical Center
1182
mi
from 91732
Lackland AFB, TX
Trial of Septra for Uncomplicated Skin Abscesses in Patients at Risk for Community Acquired Methicillin-Resistant Staphylococcus Aureus Infection
Prospective Randomized Double Blind, Placebo-Controlled Trial of Septra for Uncomplicated Skin Abscesses in Patients at Risk for Community Acquired Methicillin-Resistant Staphylococcus Aureus Infection on 30 Day Recurrence Rates.
Status: Enrolling
Updated: 12/17/2015
Wilford Hall Medical Center
1182
mi
from 91732
Lackland AFB, TX
Click here to add this to my saved trials
A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
A Phase II, Randomized, Double-Blind, Active-Controlled Clinical Study to Investigate the Efficacy and Safety of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
Status: Enrolling
Updated:  12/18/2015
Clinical Research Facility
1757
mi
from 91732
Mobile, AL
A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
A Phase II, Randomized, Double-Blind, Active-Controlled Clinical Study to Investigate the Efficacy and Safety of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
Status: Enrolling
Updated: 12/18/2015
Clinical Research Facility
1757
mi
from 91732
Mobile, AL
Click here to add this to my saved trials
A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
A Phase II, Randomized, Double-Blind, Active-Controlled Clinical Study to Investigate the Efficacy and Safety of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
Status: Enrolling
Updated:  12/18/2015
Clinical Research Facility
36
mi
from 91732
Laguna Hills, CA
A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
A Phase II, Randomized, Double-Blind, Active-Controlled Clinical Study to Investigate the Efficacy and Safety of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
Status: Enrolling
Updated: 12/18/2015
Clinical Research Facility
36
mi
from 91732
Laguna Hills, CA
Click here to add this to my saved trials
A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
A Phase II, Randomized, Double-Blind, Active-Controlled Clinical Study to Investigate the Efficacy and Safety of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
Status: Enrolling
Updated:  12/18/2015
Clinical Research Facility
21
mi
from 91732
Long Beach, CA
A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
A Phase II, Randomized, Double-Blind, Active-Controlled Clinical Study to Investigate the Efficacy and Safety of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
Status: Enrolling
Updated: 12/18/2015
Clinical Research Facility
21
mi
from 91732
Long Beach, CA
Click here to add this to my saved trials
A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
A Phase II, Randomized, Double-Blind, Active-Controlled Clinical Study to Investigate the Efficacy and Safety of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
Status: Enrolling
Updated:  12/18/2015
Clinical Research Facility
29
mi
from 91732
Sylmar, CA
A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
A Phase II, Randomized, Double-Blind, Active-Controlled Clinical Study to Investigate the Efficacy and Safety of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
Status: Enrolling
Updated: 12/18/2015
Clinical Research Facility
29
mi
from 91732
Sylmar, CA
Click here to add this to my saved trials
A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
A Phase II, Randomized, Double-Blind, Active-Controlled Clinical Study to Investigate the Efficacy and Safety of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
Status: Enrolling
Updated:  12/18/2015
Clinical Research Facility
70
mi
from 91732
Ventura, CA
A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
A Phase II, Randomized, Double-Blind, Active-Controlled Clinical Study to Investigate the Efficacy and Safety of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
Status: Enrolling
Updated: 12/18/2015
Clinical Research Facility
70
mi
from 91732
Ventura, CA
Click here to add this to my saved trials
A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
A Phase II, Randomized, Double-Blind, Active-Controlled Clinical Study to Investigate the Efficacy and Safety of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
Status: Enrolling
Updated:  12/18/2015
Clinical Research Facility
725
mi
from 91732
Idaho Falls, ID
A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
A Phase II, Randomized, Double-Blind, Active-Controlled Clinical Study to Investigate the Efficacy and Safety of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
Status: Enrolling
Updated: 12/18/2015
Clinical Research Facility
725
mi
from 91732
Idaho Falls, ID
Click here to add this to my saved trials